Cure Hydration
PrivateLast Round
Series A
Apr 17, 2023
Est. Valuation
$22M
Total Funding Raised
$8.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cure Hydration is a food and beverage company that produces plant-based, organic electrolyte drink mixes based on the World Health Organization's Oral Rehydration Solution formula.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Sports & Fitness
Business Model
B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cure Hydration Comparables
Compare Cure Hydration with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Taste Salud | 86% | |
| Ultima Replenisher | 85% | |
| Waterboy | 85% |
Cure Hydration Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 17, 2023 | ||||
| Seed | Nov 23, 2020 |
Cure Hydration Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Great Oaks Venture Capital | Series A |
| Valedor Partners | Series A |
| Litani Ventures | Seed |
| Beliade | Seed |
| Silas Capital | Series A |
| Joyance Partners | Series A |
| Simple Food Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Products are now Non-GMO Project Verified.
- Jan 1, 2026
Company is B Corp Certified.
Recent news
Latest coverage and updates
- launchesAug 27, 2026
Cure Inc. launched Hydration flavors Peach Mango and Raspberry on Aug 27th '26.
Cure Hydration Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cure Hydration's valuation, stock price, and market status.
Is Cure a public or private company?
Cure is a private company.
What is the current stock price of Cure?
Cure is a private company with no public stock price. No recent secondary market data is available.
How much is Cure worth (valuation)?
Cure's valuation is estimated at $22.0M based on funding round data.
Can I buy Cure stock?
Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cure's last funding round?
Cure's most recent funding round was Series A on April 17, 2023.
Who are the main investors in Cure?
Key investors in Cure include Lerer Hippeau.
Will Cure IPO soon?
No public IPO plans have been announced for Cure.
How can I track Cure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cure's secondary market activity and sign up for updates.